Search Results - "Fernández López, F"

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study by Newland, Adrian, Godeau, Bertrand, Priego, Victor, Viallard, Jean‐Francois, López Fernández, María F., Orejudos, Amelia, Eisen, Melissa

“…Summary In anecdotal reports, some patients with immune thrombocytopenia (ITP) maintained platelet counts after discontinuing romiplostim. Here, we examined…”
Get full text

Effect of the molecular weight and concentration of chitosan in pork model burgers by Sayas-Barberá, E., Quesada, J., Sánchez-Zapata, E., Viuda-Martos, M., Fernández-López, F., Pérez-Alvarez, J.A., Sendra, E.

“…Chitosan of high and low molecular weights was added at 0%, 0.25%, 0.5% and 1% concentrations to a burger model system. Burgers were evaluated by…”
Get full text

Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey by Windyga, J., Dolan, G., Altisent, C., Katsarou, O., López Fernández, M.-F., Zülfikar, B.

“…Introduction Desamino D‐arginine vasopressin (DDAVP or desmopressin) is a useful and effective haemostatic treatment for patients with von Willebrand Disease…”
Get full text

Combined use of a probiotic culture and citrus fiber in a traditional sausage ‘Longaniza de Pascua’ by Sayas-Barberá, E., Viuda-Martos, M., Fernández-López, F., Pérez-Alvarez, J.A., Sendra, E.

“…Combined use of Lactobacillus casei CECT 475 and orange fiber for the production of Spanish non-fermented dry-cured sausage (Longaniza de Pascua) was studied…”
Get full text

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements by PÉREZ‐ANDREU, V., ROLDÁN, V., LÓPEZ‐FERNÁNDEZ, M. F., ANTÓN, A. I., ALBERCA, I., CORRAL, J., MONTES, R., GARCÍA‐BARBERÁ, N., FERRANDO, F., VICENTE, V., GONZÁLEZ‐CONEJERO, R.

“…Background: There is currently intense debate as to whether pharmacogenetic algorithms for estimating the initial dose of coumarins provide a more accurate…”
Get full text

Hemophilic arthropathy. A scoring system for magnetic resonance imaging by Soler, R, López-Fernández, F, Rodríguez, E, Marini, M

“…The aim of this study was to define a system for scoring hemophilic arthropathy (HA) based on MR findings, providing for objective evaluation of the degree of…”
Get full text

Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients by Mingot-Castellano, María E, Moret, Andrés, de Cos, Carmen, García-Candel, Faustino, Garrido, Raquel, González-Porras, José R, López-Fernández, María F, Quintana, Laura, Rodríguez-González, Ramón, Marco, Pascual

“…We hypothesized that inhibitor specificity may predict the outcome of antifactor VIII autoantibodies eradication treatment in acquired hemophilia A. Our…”
Get full text

Botulinum toxin for the treatment of anal fissure by Fernández López, F, Conde Freire, R, Rios Rios, A, García Iglesias, J, Caínzos Fernández, M, Potel Lesquereux, J

“…The classic treatment for uncomplicated anal fissure is surgical sphincterotomy, i.e. cutting of the internal anal sphincter, thus eliminating spasm of this…”
Get more information

Acquired von Willebrand syndrome and mitral valve prosthesis leakage. A pilot study by Pérez‐Rodríguez, Almudena, Pinto, Joana Costa, Lourés, Esther, Rodríguez‐Trillo, Ángela, Cuenca, José J., Batlle, Javier, López‐Fernández, María F.

“…Background: Of patients with severe aortic stenosis, 15–25% present with bleeding episodes possibly attributable to acquired von Willebrand syndrome (AVWS)…”
Get full text

Type 2M von Willebrand disease: a variant of type 2A? by BATLLE, J., PÉREZ‐RODRÍGUEZ, A., FRANQUEIRA, M. D., LÓPEZ‐FERNÁNDEZ, M. F.

Get full text

Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007 by Asensio, A, Vaque-Rafart, J, Calbo-Torrecillas, F, Gestal-Otero, J J, López-Fernández, F, Trilla-Garcia, A, Canton, R

“…Limited information is available on the burden and epidemiology of Clostridium difficile infection (CDI) in Spain. The present report communicates the secular…”
Get full text

Advances in the therapy of von Willebrand disease by BATLLE, J., NOYA, M. S., GIANGRANDE, P., LÓPEZ-FERNÁNDEZ, M. F.

“…von Willebrand disease (vWD) is a very common autosomal inherited bleeding disorder, caused by a quantitative deficiency or a qualitative structural defect of…”
Get full text

Infectious diseases and use of health care resources in children less than 2 years-old who attend kindergarten by Domínguez Aurrecoechea, B, Fernández Francés, M, Ordóñez Alonso, M Á, López Vilar, P, Pérez Candás, J I, Merino Ramos, L, Aladro Antuña, A, Fernández López, F J, Pérez López, A M

“…Parents often ask paediatricians for advice about the best way to care for their children. There are discrepancies in the literature on this subject. The…”
Get full text

Prognostic value of nuclear morphometry in colorectal cancer by Fernández-López, F, Paredes-Cotoré, J P, Cadarso-Suárez, C, Forteza-Vila, J, Puente-Domínguez, J L, Potel-Lesquereux, J

“…In many types of cancer, certain morphometric characteristic of tumor cells correlate with patient survival. Our observations suggested that the survival of…”
Get more information

Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects by BATLLE, J, GOMEZ, E, QUINTANA, M, GONZALEZ-BOULLOSA, R, LOPEZ-FERNANDEZ, M. F, RENDAL, E, TOREA, J, LOURES, E, COUSELO, M, VILA, P, SEDANO, C, TUSELL, X, MAGALLON, M

“…Non-neutralizing factor VIII (FVIII) antibodies (FVIII-Ab) in hemophilia A may be associated with an abnormal clinical response to FVIII concentrates. Patients…”
Get full text

Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry by Fernández-López, F., Conde-Freire, R., Cadarso-Suárez, C., García-Iglesias, J., Puente-Domínguez, J. L., Potel-Lesquereux, J.

“…Objective: To find out if nuclear morphometry is a useful indicator of prognosis in patients with familial adenomatous polyposis (FAP) before and after…”
Get full text

Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey by Windyga, J., Dolan, G., Altisent, C., Katsarou, O., López Fernández, M.-F., Zülfikar, B.

“…Introduction The bleeding propensity in von Willebrand disease (VWD) is usually moderate or mild and patients with VWD do not need continuous treatment, but do…”
Get full text

Alloantibody from a patient with severe von Willebrand disease inhibits von willebrand factor-FVIII interaction by BATLLE, J, LOURES, E, VILA, P, HERNANDEZ, M. C, MENDEZ, J. A, TOREA, J, RENDAL, E, COUSELO, M. J, FILGUEIRA, A, LOPEZ-FERNANDEZ, M. F

“…The aim of this study was to analyze the ability of an alloantibody from a patient with severe von Willebrand disease (vWD) to interfere with the vWF domain…”
Get full text

Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery by Négrier, C., Abdul Karim, F., Lepatan, L. M., Lienhart, A., López-Fernández, M. F., Mahlangu, J., Pabinger, I., Li, Y., Wolko, D., Voigt, C., Jacobs, I., Santagostino, E.

“…Introduction Recombinant factor IX fusion protein (rIX‐FP) has been developed to improve the pharmacokinetic (PK) profile of factor IX (FIX), allowing…”
Get full text

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report by ASTERMARK, J., ALTISENT, C., BATOROVA, A., DINIZ, M. J., GRINGERI, A., HOLME, P. A., KARAFOULIDOU, A., LOPEZ-FERNÁNDEZ, M. F., REIPERT, B. M., ROCINO, A., SCHIAVONI, M., Von DEPKA, M., WINDYGA, J., FIJNVANDRAAT, K.

“…The development of inhibitors to the infused factor in patients with haemophilia is a serious clinical problem. Recent evidence suggests that alongside the…”
Get full text